Related Experiment Video
Updated: Jul 6, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
Clocking Recurrence: Circulating Tumor HPV DNA Kinetics in Anal Cancer
Aron Bercz1, Daniel L Faden2, J Joshua Smith1
1Department of Surgery, Colorectal Service, Memorial Sloan Kettering Cancer Center, York, New York.
None:
Detection of circulating tumor human papillomavirus (HPV) DNA 3 months after completing definitive chemoradiation for localized anal squamous cell carcinoma associates with disease recurrence and inferior recurrence-free survival. These findings provide valuable insights into the temporal significance of circulating tumor HPVDNA detection in anal cancer and its potential implications for early intervention. See related article by Morris et al., p. 2399.

